Dashboard
Manage Tickers

UTHR UNITED THERAPEUTICS Corp

Nasdaq unither.com


$ 444.23 $ -7.85 (-1.73 %)    

Friday, 07-Nov-2025 13:15:51 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 602.30 $ -6.03 (-0.99 %)
DIA $ 466.64 $ -1.57 (-0.34 %)
SPY $ 664.15 $ -3.81 (-0.57 %)
TLT $ 89.80 $ 0.44 (0.49 %)
GLD $ 368.33 $ 0.39 (0.11 %)
$ 454
$ 452.21
$ 444.15 x 6
$ 444.66 x 160
$ 444.19 - $ 452.30
$ 266.98 - $ 479.50
376,508
na
19.55B
$ 0.56
$ 15.37
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-26-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-05-2021 03-31-2021 10-Q
20 02-24-2021 12-31-2020 10-K
21 10-28-2020 09-30-2020 10-Q
22 07-29-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-27-2019 12-31-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-21-2018 12-31-2017 10-K
33 10-25-2017 09-30-2017 10-Q
34 07-27-2017 06-30-2017 10-Q
35 04-26-2017 03-31-2017 10-Q
36 02-22-2017 12-31-2016 10-K
37 10-27-2016 09-30-2016 10-Q
38 07-28-2016 06-30-2016 10-Q
39 04-28-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pe-ratio-insights-for-united-therapeutics
P/E Ratio Insights for United Therapeutics
11/07/2025 17:00:31

ubs-maintains-buy-on-united-therapeutics-raises-price-target-to-600
UBS Maintains Buy on United Therapeutics, ...
11/06/2025 18:05:32

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $580 to $600.

if-you-invested-100-in-united-therapeutics-stock-5-years-ago-you-would-have-this-much-today
If You Invested $100 In United Therapeutic...
11/04/2025 15:15:37

united-therapeutics-announced-the-first-clinical-xenotransplantation-in-its-expand-study-of-the-ukidney-in-patients-with-end-stage-renal-disease
United Therapeutics Announced The First Cl...
11/03/2025 12:07:20

United Therapeutics' UKidney is an investigational xenokidney from a pig with 10 gene edits. Six human genes are added to t...

hc-wainwright--co-maintains-buy-on-united-therapeutics-raises-price-target-to-525
HC Wainwright & Co. Maintains Buy on Unite...
10/30/2025 16:23:42

HC Wainwright & Co. analyst Andrew S. Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price t...

rbc-capital-maintains-outperform-on-united-therapeutics-raises-price-target-to-587
RBC Capital Maintains Outperform on United...
10/30/2025 15:43:02

RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target fr...

wells-fargo-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-423
Wells Fargo Maintains Equal-Weight on Unit...
10/30/2025 14:42:13

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

sp-500-tops-6900-ahead-fed-rate-move-gold-reclaims-4000-whats-moving-markets-wednesday
S&P 500 Tops 6,900 Ahead Fed Rate Move, Go...
10/29/2025 16:47:38

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...

caterpillar-posts-upbeat-q3-results-joins-united-therapeutics-centene-fortive-and-other-big-stocks-moving-higher-on-wednesday
Caterpillar Posts Upbeat Q3 Results, Joins...
10/29/2025 14:46:09

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

united-therapeutics-q3-2025-eps-716-beats-703-estimate-sales-799500m-miss-814915m-estimate
United Therapeutics Q3 2025 EPS $7.16 Beat...
10/29/2025 10:30:59

a-peek-at-united-therapeuticss-future-earnings
A Peek at United Therapeutics's Future Ear...
10/28/2025 18:01:55

if-you-invested-100-in-united-therapeutics-stock-15-years-ago-you-would-have-this-much-today
If You Invested $100 In United Therapeutic...
10/21/2025 22:00:59

united-therapeutics-to-present-latest-pulmonary-hypertension-data-at-chest-2025-in-chicago
United Therapeutics to Present Latest Pulm...
10/13/2025 11:07:41

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming...

morgan-stanley-maintains-equal-weight-on-united-therapeutics-raises-price-target-to-435
Morgan Stanley Maintains Equal-Weight on U...
10/10/2025 17:26:58

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

ubs-maintains-buy-on-united-therapeutics-raises-price-target-to-580
UBS Maintains Buy on United Therapeutics, ...
09/29/2025 13:42:15

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ: UTHR) with a Buy and raises the price target from $560 to $...

this-united-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday
This United Therapeutics Analyst Begins Co...
09/26/2025 12:03:22

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

rbc-capital-initiates-coverage-on-united-therapeutics-with-outperform-rating-announces-price-target-of-569
RBC Capital Initiates Coverage On United T...
09/26/2025 11:41:21

RBC Capital analyst Lisa Walter initiates coverage on United Therapeutics (NASDAQ: UTHR) with a Outperform rating and announ...

united-therapeutics-to-review-positive-teton-2-pivotal-study-data-of-nebulized-tyvaso-in-idiopathic-pulmonary-fibrosis-at-ers-congress-sept-28-2025-study-met-primary-and-most-secondary-endpoints
United Therapeutics To Review Positive TET...
09/19/2025 11:03:15

united-therapeutics-to-showcase-new-lung-disease-research-at-major-european-medical-conference
United Therapeutics To Showcase New Lung D...
09/12/2025 11:03:13

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its c...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION